Skip to main content
Equibles

BARCLAYS PLC

Position in CATX — Perspective Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to CATX Full portfolio

Position in CATX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$75,180
+$12,427 QoQ
Shares Held
22,047
+46.5% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 130 holders
Holding Since
Mar 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CATX Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,820,800,481 across 112 Medical Devices names. CATX ranks #68 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MDT
Medtronic plc
 6,084,725 $476,008,034
2 ABT
Abbott Laboratories
 3,863,474 $350,571,627
3 SYK
Stryker Corp
 805,637 $253,646,750
4 BSX
Boston Scientific Corp
 4,584,260 $195,656,215
5 BIO
Bio-Rad Laboratories, Inc.
 267,634 $78,580,018
6 EW
Edwards Lifesciences Corp
 775,100 $70,115,545
7 DXCM
Dexcom Inc
 999,563 $67,320,565
8 GEHC
GE HealthCare Technologies Inc.
 913,578 $58,478,126

All Filings in CATX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $75,180 22,047
2026-03-31 $62,753 15,049
2025-12-31 $255,175 92,791
2025-09-30 $287,622 83,855
2025-06-30 $355,286 103,281
2025-03-31 $123,312 57,893
2024-12-31 $302,663 94,879
2024-09-30 $1,522,901 114,075
2024-06-30 $165,322 16,582
2024-03-31 $82,117 69,006
2021-03-31 $1,891 1,735